Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma, Malignant × Cytoreduction Surgical Procedures × Clear all

Sponsor

Conditions

Ovarian Neoplasms 5 Fallopian Tube Neoplasms 4 Peritoneal Neoplasms 3 Hyperthermia 3 Carcinoma, Ovarian Epithelial 3 Recurrence 1 Mesothelioma 1 Gastrointestinal Neoplasms 1 Colonic Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Carcinoma, Renal Cell 1 Carcinoma 1 Brenner Tumor 1 Appendiceal Neoplasms 1 Adrenocortical Carcinoma 1 Abdominal Neoplasms 1

Interventions

Pemetrexed 14 Cisplatin 13 pembrolizumab 4 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 Radiotherapy 3 Gemcitabine 3 Carboplatin 3 cediranib 2 amatuximab 2 Radiotherapy, Intensity-Modulated 2 Radiation 2 Drug Therapy 2 Cyclophosphamide 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tremelimumab 1 sodium thiosulfate 1 sargramostim 1 nintedanib 1 napabucasin 1 methoxyamine 1 liposomal doxorubicin 1 incomplete Freund's adjuvant 1 fresolimumab 1 durvalumab 1 defactinib 1 cixutumumab 1 bintrafusp alfa protein, human 1 bemcentinib 1 belinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡